J&J Vaccinations Paused in U.S. on Blood Clotting Concern
The story of “safe vaccines” ending up paused never ends. In many countries now, AstraZeneca was paused or swapped for other vaccines. Johnson & Johnson just joined the squad
Now has come the turn for Johnson & Johnson’s vaccine use to be paused due to serious concerns.
We all heard about the performance of AZ vaccine, which may certainly not be excused by the “benefits higher than costs” laudatum.
“Up to 80 per cent’ in Sicily refuse AZ vaccine” (read Here).
Germany has given up on AZ for people below 60 years. for the story, even the hospital that treated Mr Navalny, the Russian political oppositionist, stopped its vaccination program with AZ. If there is a place in Germany where people must know something about toxic chemicals and their link with damage caused to the body, it must be there.
Canada has raised serious concerns over AZ and put it on hold.
The UK Government carries on saying it is safe and has now offered alternatives to young people. People wouldn’t have thought about it by themselves, so thank you, Mr Hancock.
Likewise with AZ, the J&J raises concerns, again, with blood clots.
The experimental vaccination on the population using enough untested new biotechnologies starts to bring what was foreseeable and announced by real scientists and common sense people from the start: problems. All, pushed by irresponsible politicians, at the cost of coerced and overfrightened for months vaccine recipients.
Still, the French traditional vaccine produced now in Scotland is strangely forgotten in the news and all-knowing better government advisers.
Now try to find the logic and concern for public health in all this at the moment the EU Commission had today (13th April – Committee on Civil Liberties, Justice and Home Affairs) a debate on the ‘Green certificate’ without really having left all parties interested the time to make needed research and analysis (All European ICOs, the European Data Protection Board (EDPB) and European Data Protection Supervisor had just 2 week time, i.e. 14 days).
The importance accorded to such a key unprecedented plan to interfere with individual privacy was so small that quickly emerged issues with the booking of the room and even interpreters left once the duration of the meeting ran out, leaving some speakers unable to pass on properly their questions and feedback.
Thank you for your time and interest.
Please join us by subscribing to our Blog. Posts are occasional and written as thoughts come.
Please leave your comment at the bottom of this page to continue the reflection on this post.
If you are looking for a reliable, independent professional consultancy to assist you in getting through the mist and the storm and cutting through an often artificial complexity, please do get in touch with us for an informal discussion, or write to contact @ reasonmakesense .com (please remove spaces)
Get in touch to discuss freely; reason will Make Sense, with you and for you.
A few words about Reason
reason supports Shareholders, Board, C-Suite Executives and Senior Management Team in achieving Business Excellence and Sustainability through our Praxis unique approach.
We Make Sense with you and for you.
We work and think with integrity, are independent and fed by a very broad spectrum of robust information sources, which is certainly one of the rarest and best qualities a consultancy can offer demanding decision-makers willing to overcome challenges and reach impactful, tangible and measurable Business Excellence.
We follow reason, facts, best practices, common sense and proper scientific approaches. This is our definition of professionalism. It brings reliability, confidence and peace of mind.
Please check our offering, subscribe directly on this page, write to contact @ reasonmakesense .com (without the spaces) or click on our logo below to get redirected to our contact form.
Thank you for reading!
Reason Praxis | Make Sense
Excellence & Sustainability
www.reasonmakesense.com
There is nothing wrong in doing things right, first time.
Share this post
